Alison B. Tedcastle

Potters Bar, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Production of antigenically stable enterovirus A71 virus-like particles in Pichia pastoris as a vaccine candidate.

Production of antigenically stable enterovirus A71 virus-like particles in Pichia pastoris as a vaccine candidate.

Journal: The Journal of general virology

Published: June 30, 2023

Production of antigenically stable enterovirus A71 virus-like particles in Pichia pastoris as a vaccine candidate.

Production of antigenically stable enterovirus A71 virus-like particles in Pichia pastoris as a vaccine candidate.

Journal: bioRxiv : the preprint server for biology

Published: February 13, 2023

Sustained detection of type 2 poliovirus in London sewage between February and July, 2022, by enhanced environmental surveillance.

Sustained detection of type 2 poliovirus in London sewage between February and July, 2022, by enhanced environmental surveillance.

Journal: Lancet (London, England)

Published: August 25, 2022

Detection of Enterovirus D68 in Wastewater Samples from the UK between July and November 2021.

Detection of Enterovirus D68 in Wastewater Samples from the UK between July and November 2021.

Journal: Viruses

Published: December 14, 2021

Cross-Antigenicity between EV71 Sub-Genotypes: Implications for Vaccine Efficacy.

Cross-Antigenicity between EV71 Sub-Genotypes: Implications for Vaccine Efficacy.

Journal: Viruses

Published: March 25, 2021

Differences in Antigenic Structure of Inactivated Polio Vaccines Made From Sabin Live-Attenuated and Wild-Type Poliovirus Strains: Impact on Vaccine Potency Assays.

Differences in Antigenic Structure of Inactivated Polio Vaccines Made From Sabin Live-Attenuated and Wild-Type Poliovirus Strains: Impact on Vaccine Potency Assays.

Journal: The Journal of infectious diseases

Published: November 08, 2018

Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators.

Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators.

Journal: Molecular therapy oncolytics

Published: July 19, 2016

Improved in vitro human tumor models for cancer gene therapy.

Improved in vitro human tumor models for cancer gene therapy.

Journal: Human gene therapy

Published: March 27, 2015

Actin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor Growth.

Actin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor Growth.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: March 13, 2015

Tissue-specific attenuation of oncolytic sindbis virus without compromised genetic stability.

Tissue-specific attenuation of oncolytic sindbis virus without compromised genetic stability.

Journal: Human gene therapy methods

Published: February 27, 2014

Immunogenicity in mice of human metapneumovirus with a truncated SH glycoprotein.

Immunogenicity in mice of human metapneumovirus with a truncated SH glycoprotein.

Journal: Journal of medical virology

Published: July 12, 2013

The characterization of monoclonal antibodies to human metapneumovirus and the detection of multiple forms of the virus nucleoprotein and phosphoprotein.

The characterization of monoclonal antibodies to human metapneumovirus and the detection of multiple forms of the virus nucleoprotein and phosphoprotein.

Journal: Journal of medical virology

Published: May 16, 2012

Showing 1-12 of 13

Last Updated: 09/26/2026